Biphasic 12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet
RxNorm concept 1807886, clinical drug (scd). Prescribable name: hyoscyamine sulfate 0.375 MG Biphasic 12HR Extended Release Oral Tablet.
- RxCUI
- 1807886
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1807886 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
hyoscyamine sulfate 0.375 MG Biphasic (0.125 MG / 0.25 MG) 12 HR Extended Release Oral Tablet; hyoscyamine sulfate 0.375 MG Biphasic 12 HR Extended Release Oral Tablet
Related concepts
- hyoscyamine sulfate 0.375 MG (SCDC, consists of)
- Extended Release Oral Tablet (DF, has dose form)
- Biphasic 12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet [Symax] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1807886 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1807886 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1807886. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.